Biotech Rally Fizzles: Needs Help from M&A
Biotech Rally Loses Momentum But Still Up for the Week IBB up 3.37 % , XBI up 5.04% , XLV up 0.77% this week. Investors took profits today despite all of the media focus and renewed excitement for the long term potential of new blockbuster drugs. The rally began Wednesday with the news that the...
Healthcare Stocks Lead on a Lackluster Day…Update-1… Biotech Rally Continues
Update 4/6/16 Biotech Rally Picks Up Momentum Today IBB up 4.5%,XBI up 5% Speculative stocks lead the way: BLUE up 10%, VRX up 16.6% --------Risk on mode continues--------- Healthcare Sector Leads the Market Lagging healthcare and biotech stocks found buyers today.The healthcare SPDR ETF (XLV)...
Rayno Biopharmaceuticals: New Buy Idea- Roche plc (RHBBY)
Roche/Genentech Has a Strong Pipeline in Diagnostics and Therapeutics to Drive Moderate Growth in 2016 New Stock Pick: Roche Holding (OTCQX:RHHBY) $30.36 Over the past 3 months we recommended several new buys for the Rayno Biopharma Portfolio emphasizing moderate growth, relative safety and...
Rayno Biopharmaceuticals Update 3/30-Stuck in a Trading Range with Upside Opportunities
Rayno Biopharmaceutical Portfolio Update- Biotechs with Upside Opportunity Caution No Rush to "Load Up" in a Bear Market Since Mid-January all of our previous portfolios were placed on hold and we recommended four new positions as long term holds. Here are initial prices and the current...
Busted Biotechs Week ending 3/18/16: The Only Good News Could Be Holding the February Bottom…Update 3/22
3/22/16...Update Biotech Rally Enters Fourth Day-Green Screen XBI up 7.34% Over Five Days to $52.49 Our new picks were up today: ABBV,BLUE, BMY,GILD. But Gilead Sciences (GILD) was down after hours as Merck (MRK) HCV patents were found valid in dispute. A jury will decide how much Gilead owes...